Metabolic Syndrome and Breast Cancer Risk: A Case-Cohort Study Nested in a Multicentre Italian Cohort
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Metabolic syndrome (defined as at least three among abdominal obesity, high blood triglycerides, low high-density lipoprotein cholesterol, high blood glucose, and high blood pressure) is emerging as a risk factor for breast cancer; however few studies - most confined to postmenopausal women - have investigated associations between breast cancer risk and metabolic syndrome. The purpose of this study was to examine the association between metabolic syndrome and its components, and risk of breast cancer in postmenopausal and premenopausal women. METHODS: We performed a case-cohort study on 22,494 women recruited in 1993-1998 to four Italian centres (Turin, Varese, Naples, Ragusa) of the European Prospective Investigation into Cancer and Nutrition (EPIC) and followed-up for up to 15 years. A random subcohort of 565 women was obtained and 593 breast cancer cases were diagnosed. Hazard ratios (HR) with 95% confidence intervals (CI), adjusted for potential confounders, were estimated by Prentice-weighted Cox proportional hazards models. RESULTS: Presence of metabolic syndrome was associated with significantly increased breast cancer risk in all women (HR 1.52, 95%CI 1.14-2.02). When the analyses were repeated separately for menopausal status, the association was limited to postmenopausal women (HR 1.80, 95%CI 1.22-2.65) and absent in premenopausal women (HR 0.71, 95%CI 0.43-1.16); P for interaction between metabolic syndrome and menopausal status was 0.001. Of metabolic syndrome components, only high blood glucose was significantly associated with increased breast cancer risk in all women (HR 1.47, 95%CI 1.13-1.91) and postmenopausal women (HR 1.89, 95%CI 1.29-2.77), but not premenopausal women (HR 0.80, 95%CI 0.52-1.22; P interaction=0.004). CONCLUSIONS: These findings support previous data indicating that metabolic syndrome is an important risk factor for breast cancer in postmenopausal women, but not in premenopausal women, and suggest that prevention of metabolic syndrome through lifestyle changes could confer protection against breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Some reports suggest potential harm with the use of these agents.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1719]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Other nutritional supplements, specifically resveratrol, selenium, and vitamin D, have mixed effects on glycemic control and other CV risk factors.1705,1717–1724”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1719]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Lazcano-Ponce, E. C. (2009) · Salud Pública de México · Cited by 1,669
A case-cohort design for epidemiologic cohort studies and disease prevention trials
PRENTICE, R. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.1 · Cited by 1,439
Estrogen production and action
Nelson, L. R., & Bulun, S. E. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117432 · Cited by 834 · cited 1×
“Insulin stimulates the ovarian production of androgens [38], whose aromatization in peripheral tissues is the main source of estrogen after the menopause [39]; insulin also upregulates aromatase activity [40].”
BackgroundThe Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 818 · cited 1×
“Insulin stimulates the ovarian production of androgens [38], whose aromatization in peripheral tissues is the main source of estrogen after the menopause [39]; insulin also upregulates aromatase activity [40].”
BackgroundAdiponectin as a Biomarker of the Metabolic Syndrome
Ryo, M., Nakamura, T., Kihara, S., Kumada, M., Shibazaki, S., Takahashi, M., Nagai, M., Matsuzawa, Y., & Funahashi, T. (2004) · Circulation Journal · doi:10.1253/circj.68.975 · Cited by 767 · cited 1×
“Metabolic syndrome is characterized by high levels of inflammatory cytokines [42] and leptin [43] which can promote breast cancer cell growth through various mechanisms [44, 45], and decreased levels of adiponectin [46], resulting in lack of downregulation of tumour cell proliferation and inhibition of apoptosis [45].”
BackgroundA Prospective Study of Endogenous Estrogens and Breast Cancer in Postmenopausal Women
Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P., & Pasternack, B. S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.3.190 · Cited by 620 · cited 1×
“Estrogens have a causal role in breast cancer [35], especially in postmenopausal women [36], while high levels of total and free testosterone have also been associated with increased breast cancer risk in postmenopausal women [37].”
BackgroundKaaks, R., Rinaldi, S., Key, T. J., Berrino, F., Peeters, P. H. M., Biessy, C., Dossus, L., Lukanova, A., Bingham, S., Khaw, K.-T., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01038 · Cited by 527 · cited 1×
“Estrogens have a causal role in breast cancer [35], especially in postmenopausal women [36], while high levels of total and free testosterone have also been associated with increased breast cancer risk in postmenopausal women [37].”
BackgroundSelf-citation
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Hypertension and breast cancer risk: a systematic review and meta-analysis
Han, H., Guo, W., Shi, W., Yu, Y., Zhang, Y., Ye, X., & He, J. (2017) · Scientific Reports · doi:10.1038/srep44877 · Cited by 231
“…stroke, ischemic heart disease, chronic obstructive pulmonary disease, alcoholism, alcoholic liver damage, and medication of antihypertensive agents 7 Agnoli, 2015, Italy Cohort 593 46–61 Measurement BP ≥ 130/85mmhg Cancer registry Menopausal status, parity, age at menarche, smoking, physical…”
BackgroundEffect of Ginger on Inflammatory Diseases
Ballester, P., Cerdá, B., Arcusa, R., Marhuenda, J., Yamedjeu, K., & Zafrilla, P. (2022) · Molecules · doi:10.3390/molecules27217223 · Cited by 214
“Some cancer types such as breast neoplasms [88] have been associated with inflammation [33].”
BackgroundSeretis, A., Cividini, S., Markozannes, G., Tseretopoulou, X., Lopez, D. S., Ntzani, E. E., & Tsilidis, K. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-45014-4 · Cited by 209
Silveira, E. A., Kliemann, N., Noll, M., Sarrafzadegan, N., & de Oliveira, C. (2021) · Obesity Reviews · doi:10.1111/obr.13088 · Cited by 182
The association between metabolic health, obesity phenotype and the risk of breast cancer
Park, Y., White, A. J., Nichols, H. B., O’Brien, K. M., Weinberg, C. R., & Sandler, D. P. (2017) · International Journal of Cancer · doi:10.1002/ijc.30684 · Cited by 126
“Previous studies showed little association between MetS and breast cancer in premenopausal women.(48,49) Considering that BMI increases with increasing number of metabolic abnormalities in overweight/obese women in our data (Table 1 and Supporting Information Table 1), our findings suggest that BMI may dominantly C an…”
ResultTang, G. H., Satkunam, M., Pond, G. R., Steinberg, G. R., Blandino, G., Schünemann, H. J., & Muti, P. (2018) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0936 · Cited by 117
The potential contribution of dietary factors to breast cancer prevention
Shapira, N. (2017) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000406 · Cited by 82
“Some nutrients may be leached out, whereas others – such as carrot and pepper carotenoids – become more available when cooked in oil, especially olive oil, which increases bioavailability and is itself rich in anti-BC compounds (Agnoli et al., 2015).”
BackgroundThe Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis
Zhao, P., Xia, N., Zhang, H., & Deng, T. (2020) · Obesity Facts · doi:10.1159/000507554 · Cited by 60
Metabolic Risk Profile and Cancer in Korean Men and Women
Ko, S., Yoon, S., Kim, D., Kim, A., Kim, E. J., & Seo, H.-Y. (2016) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.16.021 · Cited by 67
“65) [28].”
Poles, J., Karhu, E., McGill, M., McDaniel, H. R., & Lewis, J. E. (2021) · Journal of Clinical and Translational Research · doi:10.18053/jctres.07.202103.004 · Cited by 66
“Patients with MetSyn were randomized for 4 weeks to receive either 300 mg/day of α-lipoic acid or placebo [14].”
BackgroundInfluentialSantos, A. P., Santos, A. C., Castro, C., Raposo, L., Pereira, S. S., Torres, I., Henrique, R., Cardoso, H., & Monteiro, M. P. (2018) · Cancers · doi:10.3390/cancers10090293 · Cited by 58
Guo, M., Liu, T., Li, P., Wang, T., Zeng, C., Yang, M., Li, G., Han, J., Wu, W., & Zhang, R. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01290 · Cited by 52
Expression of LXR‑β, ABCA1 and ABCG1 in human triple‑negative breast cancer tissues
Pan, H., Zheng, Y., Pan, Q., Chen, H., Chen, F., Wu, J., & Di, D. (2019) · Oncology Reports · doi:10.3892/or.2019.7279 · Cited by 53
“Metabolic syndrome has been confirmed as a risk factor for breast cancer among post-menopausal women and is defined as having at least three of the following: Abdominal obesity, hyperlipidemia, high levels of low-density lipoprotein, high blood glucose and high blood pressure (7).”
BackgroundInfluentialAgresti, R., Meneghini, E., Baili, P., Minicozzi, P., Turco, A., Cavallo, I., Funaro, F., Amash, H., Berrino, F., Tagliabue, E., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3802-3 · Cited by 51
Metabolic Syndrome and the Risk of Breast Cancer and Subtypes by Race, Menopause and BMI
Dibaba, D. T., Braithwaite, D., & Akinyemiju, T. (2018) · Cancers · doi:10.3390/cancers10090299 · Cited by 48
“Other case-control [11,37] and case-cohort studies [38] have also shown strong associations between MetS and breast cancer.”
ResultXiang, Y., Zhou, W., Duan, X., Fan, Z., Wang, S., Liu, S., Liu, L., Wang, F., Yu, L., Zhou, F., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00905 · Cited by 40
Karimi, N., Dabidi Roshan, V., & Fathi Bayatiyani, Z. (2015) · Iranian Journal of Cancer Prevention · doi:10.17795/ijcp-3856 · Cited by 36
“Also, the homeostasis model assessment for insulin resistance (HOMA-IR) as determined by the following equation (3):”
BackgroundMethodHeritable shifts in redox metabolites during mitochondrial quiescence reprogramme progeny metabolism
Hocaoglu, H., Wang, L., Yang, M., Yue, S., & Sieber, M. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00450-3 · Cited by 38
The molecular mechanisms between metabolic syndrome and breast cancer
Chen, Y., Wen, Y.-Y., Li, Z.-R., Luo, D., & Zhang, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.034 · Cited by 38
“Among the MS, high fasting gl ucose was significantly associated with increased BC risk in all women [33] .”
BackgroundLuque, R. M., Lopez-Sanchez, L. M., Villa-Osaba, A., Luque, I. M., Santos-Romero, A. L., Yubero‐Serrano, E. M., García, M. C., Benito, M. Á., López‐Miranda, J., Gahete, M. D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20399 · Cited by 36
“Indeed, IR is associated to hyperinsulinemia, hypertension, and impaired glucose tolerance, and, consequently, has been proposed as a putative underlying cause in the relationship of obesity, diabetes, and metabolic syndrome with higher BCa risk [2, 8, 11, 12], prognosis [7, 13] and survival [3, 14].”
BackgroundCorrelation analysis of metabolic syndrome and its components with thyroid nodules
Liu, J., Wang, C., Tang, X., Fu, S., Jing, G., Ma, L., Sun, W., Li, Y., Wu, D., Niu, Y., et al. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s219019 · Cited by 34
Modifiable Risk Factors for the Development of Breast Cancer in Young Women
Cathcart-Rake, E. J., Ruddy, K. J., & Johnson, R. H. (2018) · The Cancer Journal · doi:10.1097/ppo.0000000000000340 · Cited by 32
Cazzaniga, M., & Bonanni, B. (2018) · Anticancer Research · doi:10.21873/anticanres.12741 · Cited by 31
Matthews, A., Hinton, S. P., Stanway, S. J., Lyon, A. R., Smeeth, L. L., Bhaskaran, K., & Lund, J. L. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.7629 · Cited by 30
Arthur, R., Dannenberg, A. J., & Rohan, T. E. (2021) · International Journal of Cancer · doi:10.1002/ijc.33508 · Cited by 30
Vegunta, S., Lester, S. P., Pruthi, S., & Mussallem, D. M. (2020) · Breast Cancer Management · doi:10.2217/bmt-2020-0033 · Cited by 30
Lancellotti, P., Galderisi, M., Donal, E., Edvardsen, T., Popescu, B. A., Farmakis, D. T., Filippatos, G. S., Habib, G., Lestuzzi, C., Santoro, C., et al. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12162 · Cited by 25
de Miranda, F. S., Guimarães, J. P. T., Menikdiwela, K. R., Mabry, B., Dhakal, R., Rahman, R. L., Moussa, H. M., & Moustaïd‐Moussa, N. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111245 · Cited by 24
Obesity and breast cancer: Preventive and therapeutic possibilities for bariatric surgery
Crafts, T. D., Tonneson, J. E., Wolfe, B. M., & Stroud, A. (2022) · Obesity · doi:10.1002/oby.23369 · Cited by 24
Krusińska, B., Wądołowska, L., Słowińska, M. A., Biernacki, M., Drozdowski, M., & Chadzynski, T. (2018) · Nutrients · doi:10.3390/nu10122013 · Cited by 24
“In regards to the glucose and insulin, as a component of the ‘Metabolic-Syndrome’ profile, some data suggest that elevated serum levels of these markers may be considered as predictors for breast cancer [33,38,57], however, there is not enough evidence [37,54,55].”
BackgroundResultInfluentialWu, J., Lei, X., Pan, X., Zeng, X., & Li, W. (2021) · Journal of International Medical Research · doi:10.1177/03000605211061033 · Cited by 23
Ayeni, O., Joffe, M., Cubasch, H., Rinaldi, S., Taljaard‐Krugell, C., Vorster, E., Romieu, I., & Norris, S. A. (2019) · South African Medical Journal · doi:10.7196/samj.2019.v109i4.13465 · Cited by 21
“[22,50] There was no significant difference in our study with regard to individual metabolic disease components (obesity, dyslipidaemia, hypertension and hyperglycaemia) or in the number of metabolic diseases with which women with and without breast cancer presented; however, the proportion of women presenting with me…”
BackgroundPersistent vasomotor symptoms and breast cancer in the Women's Health Initiative
Chlebowski, R. T., Mortimer, J. E., Crandall, C. J., Pan, K., Manson, J. E., Nelson, R. A., Johnson, K., Vitolin, M. Z., Lane, D. S., Wactawski‐Wende, J., et al. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001283 · Cited by 20
“Presence of VMS and other menopausal symptoms has been associated with cardiovascular disease risk factors(17-19) including homeostatic model assessment of insulin resistance(20) and the metabolic syndrome,(21) factors which are also associated with higher breast cancer risk.(22,23) The association of VMS with risk fa…”
BackgroundHäggström, C., Jönsson, H., Bjørge, T., Nagel, G., Manjer, J., Ulmer, H., Drake, I., Ghaderi, S., Lang, A. H., Engeland, A., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32240 · Cited by 20
“Our findings for triglycerides and breast cancer risk were similar to those for BMI, and likewise, results from observational studies of triglycerides reflected those of BMI with a graded association by menopause or menopausal age.(5,26,27) The largest study to date on triglycerides and breast cancer risk showed a sug…”
ResultShen, J., Hernandez, D. C., Ye, Y., Wu, X., Chow, W., & Zhao, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-46429-9 · Cited by 20
Revisión de los factores de riesgo y factores protectores para el cáncer de mama
Astorga-Ramírez, A., Sánchez-Portuguez, J., & Solis-Barquero, S. (2022) · Acta Médica Costarricense · doi:10.51481/amc.v64i4.1177 · Cited by 18
From physiology to psychology: An integrative review of menopausal syndrome
Lang, X., Huang, C., Cui, H.-Y., Zhong, H., Shen, M.-Y., & Zhao, F. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i11.108713 · Cited by 17
Zhao, J., Tian, Y., Yao, J., He, G., Zhang, R., Wang, H., Liao, L., & Dong, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.508126 · Cited by 17
Cancer and comorbidity: The role of leptin in breast cancer and associated pathologies
Ray, A. (2018) · World Journal of Clinical Cases · doi:10.12998/wjcc.v6.i12.483 · Cited by 17
Metabolic syndrome and breast cancer risk
Mohammed, A. M., Hamed, H. B., Noaman, M. K., & Alieldin, N. (2023) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-023-00203-1 · Cited by 15
Wu, Y., Luo, Q.-Q., Li, X., Arshad, B., Xu, Z., Liang, R., Zhao, C., Wu, H., Shi, Y., Chen, H.-R., et al. (2018) · Journal of Cancer · doi:10.7150/jca.22968 · Cited by 14
“Recently, several studies showed that metabolic syndrome has increased the risk of breast cancer occurrence, recurrence and breast cancer specific mortality [8, 10, 14, 15].”
BackgroundThe molecular mechanisms linking metabolic syndrome to endometrial and breast cancers
Lazăr, A.-L., Vulturar, R., Fodor, A., Orasan, O. H., Crișan, C.-H., Login, C., Para, I., Negrean, V., Tiperciuc, B., & Cozma, A. (2021) · Journal of Mind and Medical Sciences · doi:10.22543/7674.82.p167178 · Cited by 12
The Microbiome in the Obesity-Breast Cancer Axis: Diagnostic and Therapeutic Potential
Avtanski, D. B., Reddy, V. V., Stojchevski, R., Hadzi‐Petrushev, N., & Mladenov, M. I. (2023) · Pathogens · doi:10.3390/pathogens12121402 · Cited by 12
Blood pressure and risk of breast cancer, overall and by subtypes: a prospective cohort study
Yang, Y., Lynch, B. M., Hodge, A. M., Liew, D., McLean, C., Seviiri, M., Southey, M. C., Hopper, J. L., English, D. R., Giles, G. G., et al. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001372 · Cited by 11
Characterisation of a Mouse Model of Breast Cancer with Metabolic Syndrome
Buss, L. A., Mandani, A. N. D., Phillips, E., Scott, N. J. A., Currie, M. J., & Dachs, G. U. (2018) · In Vivo · doi:10.21873/invivo.11348 · Cited by 11
Motoki, A. H., Buttros, D. D. A. B., Gaspar, A. L. C., Almeida-Filho, B. S., Pessoa, E. C., Véspoli, H. D. L., Nahás-Neto, J., & Nahás, E. A. P. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.07.009 · Cited by 11
Li, L., Meng, F., Xu, D., Xu, L., Qiu, J., & Shu, X. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061362 · Cited by 9
Onal, H. Y., Bayram, B., & Yuksel, A. (2021) · Nutrition Research and Practice · doi:10.4162/nrp.2021.15.s1.s53 · Cited by 9
“Many studies have shown that there is a strong correlation between the prevalence of obesity and increased risk of chronic diseases, such as cardiovascular diseases, type 2 diabetes, and some cancer types [22-26].”
BackgroundLi, F., & Gao, Z. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5825 · Cited by 7
“Epidemiological studies have established a clear association between obesity and an increased risk of BC, particularly in postmenopausal women (11,12).”
Lee, J., Chang, Y., Kim, Y., Park, B., & Ryu, S. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06513-7 · Cited by 7
López‐Jiménez, T., Plana‐Ripoll, O., Duarte‐Salles, T., Recalde, M., Bennett, M., Cos, X., & Puente, D. (2024) · Cancer Medicine · doi:10.1002/cam4.7400 · Cited by 6
Fontana, L., Sieri, S., Ricceri, F., Agnoli, C., Pala, V. M., Masala, G., Saieva, C., Catalano, A., Macciotta, A., Tumino, R., et al. (2022) · Nutrition and Healthy Aging · doi:10.3233/nha-210145 · Cited by 6
Self-citationFlores-García, L. C., Ventura-Gallegos, J. L., Romero-Cordoba, S. L., Hernández-Juárez, A. J., Naranjo-Meneses, M. A., García‐García, E., Méndez, J. P., Cabrera-Quintero, A. J., Ramírez-Ruíz, A., Pedraza‐Sánchez, S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266073 · Cited by 6
Li, B., Liu, Y., Yuan, Q., Lin, Q., Shi, W., Zhu, P., Min, Y., Ge, Q., & Shao, Y. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820984180 · Cited by 6
“MS was reported as a significant risk factor for PBC in 22,494 case-cohort study performed by Agnoli C et al.(22) Moreover, a study involving 3,460 subjects demonstrated that a high level of body fat contributed to an increased risk of PBC at a normal BMI.”
BackgroundSingh, V., Reddy, R., Sinha, A., Marturi, V., Panditharadyula, S. S., & Bala, A. (2020) · Current Cancer Therapy Reviews · doi:10.2174/1573394716999200831113335 · Cited by 6
Modifiable and Nonmodifiable Risk Factors for Breast Cancer: A Comprehensive Scoping Review
Momenimovahed, Z., Shahabinia, Z., Allahqoli, L., & Salehiniya, H. (2026) · International Journal of Breast Cancer · doi:10.1155/ijbc/8689986 · Cited by 5
“Metabolic syndrome is associated with an increased risk of breast cancer [122–131], and this risk is significantly greater in postmenopausal women than in premenopausal women [123, 127, 128, 130, 132–136].”
InfluentialDiet and Cancer Metabolic Reprogramming
Bhattacharya, S. (2021) · Cancer Reports and Reviews · doi:10.15761/crr.1000233 · Cited by 4
Barranco, M. M., Zecchinati, F., Perdomo, V., Habib, M. J., Rico, M. J., Rozados, V. R., Salazar, M., Fusini, M. E., Scharovsky, O. G., Villanueva, S. S. M., et al. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.117130 · Cited by 4
León-Díaz, R., Chaparro-García, M., López-Mora, G., Meza, S. H., Monroy, A., Barranca-Enríquez, A., & Romo‐González, T. (2019) · Revista de Senología y Patología Mamaria · doi:10.1016/j.senol.2019.01.003 · Cited by 4
“Estado civil Soltera 28(25,68) 24 (25,80) Casada 58(53,21) 63 (67,74) Viuda 16(14,67) 5 (5,37) Divorciada 7(6,42) 1(1,07)”
van der Merwe, N. (2016) · SUNScholar (Stellenbosch University) · Cited by 4
Jahani, M. A., Ghasemi, B., Soltani, S. A., Naderi, M., Nikbakht, H., Hashemi, S. N., Charati, J. Y., & Mahmoudi, G. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002114 · Cited by 2
Associação entre subtipos intrínsecos de câncer de mama e IMC elevado: revisão sistemática
da Silva, J. G., Cordeiro, G. G. S., Costa, F. B. S., Brock, Y. D. B., de Andrade, A. B., Cardoso, H. M. V. L., Alves, J. R. D. A., Pereira, I. M. M., Figueredo, E. P. R., & de Vasconcelos, A. S. (2023) · Scire Salutis · doi:10.6008/cbpc2236-9600.2023.002.0010 · Cited by 2
Metabolic Syndrome and Breast Cancer: Is There a Cause-and-Effect Relationship?
Negi, P., Kingsley, P. A., Jacob, J. J., Sachdeva, J., & Jomi, C. (2022) · Journal of Radiation and Cancer Research · doi:10.4103/jrcr.jrcr_43_22 · Cited by 2
Association between allostatic load and risk of breast carcinoma in situ in the UK biobank
Fengfu, C., Hua, X., Chen, X., Liu, M., Chen, A., Wan, B., Sun, H., Liang, H., Du, S., & Xie, D.-H. (2026) · Cancer Causes & Control · doi:10.1007/s10552-026-02186-5 · Cited by 1
“Previous epidemiological studies have consistently linked individual metabolic syndrome components and composite AL indices to increased overall breast cancer incidence and mortality [4, 35, 36].”
Metabolites Associated with Polygenic Risk of Breast Cancer
Samuels, E., Parks, J., Chu, J., McDonald, T., Spinelli, J. J., Murphy, R. A., & Bhatti, P. (2024) · Metabolites · doi:10.3390/metabo14060295 · Cited by 1
“High triglyceride levels are associated with metabolic disease, which is, itself, associated with increased breast cancer risk [29].”
BackgroundAssociation of sporadic and familial Barrett's esophagus with breast cancer
Chan, M. Q., Blum, A. E., Chandar, A. K., Emmons, A., Shindo, Y., Brock, W. E., Falk, G. W., Canto, M. I., Wang, J. S., Iyer, P. G., et al. (2018) · Diseases of the Esophagus · doi:10.1093/dote/doy007 · Cited by 1
PAPEL DOS NÍVEIS SÉRICOS DE VITAMINA D E DA SÍNDROME METABÓLICA E O RISCO DE CÂNCER DE MAMA
Fernandes, E. M. A., & Linhares, J. J. (2021) · Arquivos Catarinenses de Medicina · doi:10.63845/888g5j24 · Cited by 1
Xiang, Y., Zhou, W., Duan, X., Fan, Z., Wang, S., Liu, S., Liu, L., Wang, F., Yu, L., Zhou, F., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00227 · Cited by 1
Huang, J. (2025) · Hepatology · doi:10.1097/hep.0000000000001369 · Cited by 1
Metabolic Syndrome and Breast Cancer Risk: an Age-Dependent Paradox?
Şanlı, D. E. T., & Şanlı, A. N. (2025) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-025-07802-1 · Cited by 1
“However, the current study’s finding of a “lower” overall incidence may differ from some large cohorts and meta-analyses, particularly from Western populations [4, 5 ].”
Association of metabolic alterations with prognostic factors in malignant breast neoplasms
Nomelini, R. S., Navaro, F. S. D. O. F., Pena, A. L. B., Tavares‐Murta, B. M., & Murta, E. F. C. (2015) · Revista Brasileira de Mastologia · doi:10.5327/z201500030003rbm
The Role of Diet in Breast Cancer Prevention
Shapira, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-27135-4_9
Neoplasia in Patients with Excess Fat Mass
Hurley, D. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-95655-8_17
Hertelyová, Z., Radoňak, J., Cimboláková, I., Guľašová, Z., & Široká, M. (2019) · Acta Salus Vitae
dos Santos, A. P. S. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/v14z-w896
Manni, S. T., Mathialagan, A., Karisnan, K., & Noris, C. P. (2021) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20212619
Exposure to Second-Hand Smoke Predicts Breast Cancer Occurrence among Malaysian Women
Rashid, A. A. A., Zahali, Z., Gan, S. H., Krishna, B. V. M., Abdullah, S., Abdullah, S. Z. S., & Mohamed, H. J. J. (2022) · Sains Malaysiana · doi:10.17576/jsm-2022-5103-17
“Thus, the increase in systolic blood pressure in the present study may possibly be influenced by breast cancer simply due to the extra stress of attending an oncology appointment in the hospital (Agnoli et al. 2015).”
BackgroundSíndrome metabólico e incidencia y mortalidad por cáncer entre la población catalana
López‐Jiménez, T. (2025) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Tutkuvienė, J., Gervickaitė, S., Drąsutis, J., Sakalauskaitė, I., Šimkūnaitė-Rizgelienė, R., Jablonskienė, V., Barkus, A., Jakimaviciene, E. M., Karčiauskaitė, D., Kaminskas, A., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-41646-5
“In general, the so-called “V” shaped subcutaneous adipose tissue topography, based on numerous other studies 38,39,41,43–46, 66 , is”
To Study the Association between Metabolic Syndrome and Breast Cancer among Premenopausal Females
Priya, S., Shukla, V., & Verma, A. (2026) · Indian Journal of Medical Specialities · doi:10.4103/injms.injms_163_26
Lee, K. H., Kim, E. Y., Park, C. H., Park, Y. L., Yun, J. S., & Kim, Y. T. (2026) · Cancer Epidemiology · doi:10.1016/j.canep.2026.103266
Metadata
- Authors
- Agnoli, C., Grioni, S., Sieri, S., Sacerdote, C., Ricceri, F., Tumino, R., Frasca, G., Pala, V., Mattiello, A., Chiodini, P., Iacoviello, L., De Curtis, A., Panico, S., & Krogh, V.
- Affiliations
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Italian institute for Genomic Medicine (IT)
- University of Ragusa (IT)
- University of Naples Federico II (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Istituto Neurologico Mediterraneo (IT)
- Corresponding author
- Sieri, Sabina
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-06-01
- Volume
- 10
- Issue
- 6
- Pages
- e0128891
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4452341
- OpenAlex
- W646343780
- Cited by
- 76
- References
- 52
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 9 · 2021: 15 · 2020: 5 · 2019: 8 · 2018: 12 · 2017: 6 · 2016: 4 · 2015: 2
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion, cc-by-nc-nd)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IrInSubria (University of Insubria) (submittedVersion)
- Funders
- Compagnia di San Paolo
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- breast cancer risk, postmenopausal women, premenopausal women, menopausal status, hyperglycemia, abdominal obesity, dyslipidemia, hypertension, EPIC cohort, risk factors, cancer prevention, Mediterranean diet, breast cancer screening, early detection, early treatment, early mortality
- MeSH terms
- Blood Glucose, Breast Neoplasms, Female, Humans, Hypertension, Italy, Life Style, Prospective Studies, Risk Factors, Case-Control Studies, Premenopause, Postmenopause, Metabolic Syndrome, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.